NAMSA Expands Medical Device Testing Services in Germany to Increase Access to Accelerated Product Development
The world’s only Medical Research Organization brings 50 years of testing leadership to Germany with new Analytical Services Laboratory.
FRANKFURT, GERMANY – February 1, 2018 – NAMSA, the world’s only Medical Research Organization (MRO) that accelerates medical device development through integrated testing, clinical research and regulatory consulting services, is pleased to announce the launch of its state-of-the-art Analytical Services Laboratory in Obernburg, Germany. The opening of this laboratory represents the organization’s fourth European location and NAMSA’s growing investment in Europe’s largest medical device market.
The new facility, located one hour from Frankfurt, will offer European device manufacturers a centrally-located site for ISO 10993-18 testing requirements and provide further conveniences for exhaustive extraction, FTIR, GC-MS, LC-MS and ICP-MS services in the region.
“NAMSA is excited to add to its global portfolio of services with the introduction of its new Obernburg laboratory,” commented Ulrich Gohlke, Director of German Lab Operations, NAMSA. “NAMSA is proud of its strong working relationships with EU regulatory entities, including the European Commission, and demonstrated track record of delivering significant time and cost savings throughout the medical device development continuum. With the introduction of NAMSA’s new Analytical Services Laboratory, we look forward to providing European device makers significant development efficiencies, including closer collaboration through an ideally-located testing partner.”
NAMSA is a leading Contract Research Organization (CRO) – and the world’s only Medical Device Organization (MRO) – that supports clients throughout all stages of the medical device development lifecycle. From concept and feasibility testing to post-market surveillance, services provided by NAMSA have been proven to accelerate time-to-market and reduce costs for product research and market introduction. By leveraging a half century of technical expertise, and drawing upon 1,000 highly knowledgeable global Associates, NAMSA is the industry leader in balancing speed and quality with proven scientific approaches.
Leah Davidson, MA, MBA, PCM
Leah has been with NAMSA since 2016 and currently serves as Senior Manager of Global Marketing Communications. She possesses nearly 25 years' experience within the medical device and healthcare technology industries and has worked in various marketing and communications capacities throughout her career. In her role at NAMSA, she is responsible for the development and implementation of brand strategies and marketing communications initiatives that help drive the organization's sales and organizational growth goals globally.